The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...

From the ancient Egyptians' use of electric fish to treat headaches to the invention of pacemakers to regulate heart rhythms in the 1950s, the field ...

1. Onward Medical's Arc-EX spinal cord stimulator saw its first U.S. sales in late December, the company said Jan. 9. 2. Saluda Medical closed a $100 million finance round. The money will support ...

Spinal cord stimulation can be an effective treatment for managing ... In addition, their FDA-approved closed-loop Inceptiv SCS system addresses the variability in patient experience by sensing neural ...

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its closed-loop ... The company’s Evoke spinal cord stimulator, approved by ...

The Evoke® System is a physiologic closed-loop, dose-control spinal cord stimulation (SCS) system designed for chronic pain management. Chronic pain affects an estimated 20% of the world's ...